A double blind study on fluvoxamine vs. placebo in depressed HIV positive patients: Short-term and perspective results

M. C. Mauri, A. Ferrara, L. Fabiano, C. Ricci, G. Invernizzi

Research output: Contribution to journalArticle


Twenty-six HIV positive patients were included in the study. Sixteen patients were treated with fluvoxamine 100-150 mg/die p.o. t.i.d. and 10 patients were treated with placebo for 8 weeks under double-blind conditions. Patients treated with fluvoxamine showed a significant HAM-D improvement (p <0.01). Eleven of the 26 patients died within a year of the end of the trial. They showed a higher T0 and T8 HAM-D total score compared to the surviving patients with a significantly higher T8 HAM-D score (p <0.01) in patients treated with placebo.

Original languageEnglish
Pages (from-to)199-201
Number of pages3
JournalIntegrative Psychiatry
Issue number4
Publication statusPublished - 1994



  • Fluvoxamine
  • HIV+ patients

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this